A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
Clinical trial NCT04126876 · RECRUITING
Trial details
- NCT number
- NCT04126876
- Sponsor
- A.J.M. van den Eertwegh
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2021-11-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.